These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 6151221

  • 1. Inhibition of transglutaminase by hypoglycaemic sulphonylureas in pancreatic islets and its possible relevance to insulin release.
    Gomis R, Mathias PC, Lebrun P, Malaisse-Lagae F, Sener A, Malaisse WJ.
    Res Commun Chem Pathol Pharmacol; 1984 Dec; 46(3):331-49. PubMed ID: 6151221
    [Abstract] [Full Text] [Related]

  • 2. Sulphonylureas do not increase insulin secretion by a mechanism other than a rise in cytoplasmic Ca2+ in pancreatic B-cells.
    Garcia-Barrado MJ, Jonas JC, Gilon P, Henquin JC.
    Eur J Pharmacol; 1996 Mar 18; 298(3):279-86. PubMed ID: 8846827
    [Abstract] [Full Text] [Related]

  • 3. Hypoglycaemic and insulinotropic effects of a novel oral antidiabetic agent, (-)-N-(trans-4-isopropylcyclohexanecarbonyl)-D-phenylalanine (A-4166).
    Ikenoue T, Akiyoshi M, Fujitani S, Okazaki K, Kondo N, Maki T.
    Br J Pharmacol; 1997 Jan 18; 120(1):137-45. PubMed ID: 9117089
    [Abstract] [Full Text] [Related]

  • 4. Transglutaminase activity in pancreatic islets.
    Gomis R, Sener A, Malaisse-Lagae F, Malaisse WJ.
    Biochim Biophys Acta; 1983 Nov 08; 760(3):384-8. PubMed ID: 6138101
    [Abstract] [Full Text] [Related]

  • 5. Therapeutical concentrations of tolbutamide, glibenclamide, gliclazide and gliquidone at different glucose levels: in vitro effects on pancreatic A- and B-cell function.
    Gregorio F, Ambrosi F, Cristallini S, Pedetti M, Filipponi P, Santeusanio F.
    Diabetes Res Clin Pract; 1992 Dec 08; 18(3):197-206. PubMed ID: 1289021
    [Abstract] [Full Text] [Related]

  • 6. The ability of a new hypoglycaemic agent, A-4166, compared to sulphonylureas, to increase cytosolic Ca2+ in pancreatic beta-cells under metabolic inhibition.
    Fujitani S, Okazaki K, Yada T.
    Br J Pharmacol; 1997 Apr 08; 120(7):1191-8. PubMed ID: 9105692
    [Abstract] [Full Text] [Related]

  • 7. Role of transglutaminase in insulin release. Study with glycine and sarcosine methylesters.
    Sener A, Dunlop ME, Gomis R, Mathias PC, Malaisse-Lagae F, Malaisse WJ.
    Endocrinology; 1985 Jul 08; 117(1):237-42. PubMed ID: 2408879
    [Abstract] [Full Text] [Related]

  • 8. Metabolic, cationic and secretory effects of hypoglycemic sulfonylureas in pancreatic islets.
    Kawazu S, Sener A, Couturier E, Malaisse WJ.
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Jul 08; 312(3):277-83. PubMed ID: 6995864
    [Abstract] [Full Text] [Related]

  • 9. Glucose modulates the amount, but not the kinetics, of insulin released by sulfonylureas.
    Gregorio F, Ambrosi F, Filipponi P, Cristallini S, Santeusanio F.
    J Diabetes Complications; 1994 Jul 08; 8(4):204-12. PubMed ID: 7833495
    [Abstract] [Full Text] [Related]

  • 10. [Experimental study of glipizide. A comparison with other hypoglycemic sulfonamides (author's transl)].
    Loubatières AL, Loubatieres-Mariani MM, Alric R, Ribes G, Sorial G, Tarasco A.
    Diabete Metab; 1975 Mar 08; 1():13-21. PubMed ID: 824163
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Interacting effects of sulfonylureas and glucose on cyclic AMP metabolism and insulin release in pancreatic islets of the rat.
    Grill V, Cerasi E.
    J Clin Invest; 1978 May 08; 61(5):1346-54. PubMed ID: 207736
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The inhibition of glucose-stimulated insulin secretion by primary amines. A role for transglutaminase in the secretory mechanism.
    Bungay PJ, Potter JM, Griffin M.
    Biochem J; 1984 May 01; 219(3):819-27. PubMed ID: 6146312
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A role for transglutaminase in glucose-stimulated insulin release from the pancreatic beta-cell.
    Bungay PJ, Owen RA, Coutts IC, Griffin M.
    Biochem J; 1986 Apr 01; 235(1):269-78. PubMed ID: 2874792
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Dynamics of sulfonylurea-induced insulin release from the isolated perfused rat pancreas.
    Gotfredsen CF.
    Diabetologia; 1976 Aug 01; 12(4):339-42. PubMed ID: 134920
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.